Results 341 to 350 of about 1,425,061 (397)
Some of the next articles are maybe not open access.
Neoadjuvant or adjuvant chemotherapy in early breast cancer?
Expert Opinion on Pharmacotherapy, 2020Introduction The administration of chemotherapy before (neoadjuvant), rather than after surgery (adjuvant) in early breast cancer has been considered an optional strategy for patients with operable breast cancer.
F. Montemurro +2 more
semanticscholar +1 more source
Adjuvant castration versus adjuvant chemotherapy
International Journal of Radiation Oncology*Biology*Physics, 1978Furthermore, in premenopausal women under 45 years of age Meakin et al.” failed to observe a significant difference in terms of delay of recurrence and prolongation of survival between those who had radical mastectomy (RM) and RM plus ovarian irradiation (RT). Since histologically positive axillary lymph nodes were identified in 87% (RM) and in 98% (RT)
openaire +2 more sources
Archives of Surgery, 1977
The remarks of Drs Jamieson and Ludbrook revive recent controversy in major scientific journals and in the public press. However, adjuvant chemotherapy has been widely accepted by the public and the profession; there is a case for presenting the alternative view.
openaire +2 more sources
The remarks of Drs Jamieson and Ludbrook revive recent controversy in major scientific journals and in the public press. However, adjuvant chemotherapy has been widely accepted by the public and the profession; there is a case for presenting the alternative view.
openaire +2 more sources
JAMA, 1984
JUST a little over eight years ago I expressed my concerns 1 about the uncritical and premature acceptance of the results of the then recently published adjuvant study by the National Surgical Breast Project (NSABP). 2 The NSABP report detailed early results of a randomized study of patients who had undergone mastectomy with axillary lymph nodes ...
openaire +3 more sources
JUST a little over eight years ago I expressed my concerns 1 about the uncritical and premature acceptance of the results of the then recently published adjuvant study by the National Surgical Breast Project (NSABP). 2 The NSABP report detailed early results of a randomized study of patients who had undergone mastectomy with axillary lymph nodes ...
openaire +3 more sources
Journal of Clinical Oncology, 2018
Purpose To update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer.
N. Denduluri +14 more
semanticscholar +1 more source
Purpose To update key recommendations of the ASCO guideline adaptation of the Cancer Care Ontario guideline on the selection of optimal adjuvant chemotherapy regimens for early breast cancer and adjuvant targeted therapy for breast cancer.
N. Denduluri +14 more
semanticscholar +1 more source
Adjuvant Intravesical Chemotherapy
2021In 2018, there were an estimated 81,000 new cases of bladder cancer in the USA with over 17,000 cancer-related deaths.(Siegel et al., CA Cancer J Clin. 68:7–30, 2018) About 75% of these newly diagnosed cases are nonmuscle-invasive bladder cancer (NMIBC).
Christopher R. Haas +2 more
openaire +1 more source
Archivio italiano di urologia, nefrologia, andrologia : organo ufficiale dell'Associazione per la ricerca in urologia = Urological, nephrological, and andrological sciences, 1991
The authors treated 10 advanced renal cell carcinoma with circadian venous continuous infusion of 5-Fluoro 2-Deoxyuridine (FUDR). The drug was delivered by Medtronic Synchromed implantable pump in 14-day cycles alternating with 14-day intervals of physiologic saline infusion.
A, Del Nero +6 more
openaire +1 more source
The authors treated 10 advanced renal cell carcinoma with circadian venous continuous infusion of 5-Fluoro 2-Deoxyuridine (FUDR). The drug was delivered by Medtronic Synchromed implantable pump in 14-day cycles alternating with 14-day intervals of physiologic saline infusion.
A, Del Nero +6 more
openaire +1 more source
Adjuvant chemotherapy in pancreatic cancer
International journal of pancreatology, 1997There is increasing interest in the use of adjuvant treatment for pancreatic cancer since although postoperative mortality is much improved, median long-term survival is only on the order of 11-15 mo. Despite a proliferation of studies in advanced pancreatic cancer indicating a benefit for chemotherapy, there has only been one small randomized adjuvant
S R, Bramhall, J P, Neoptolemos
openaire +2 more sources
Adjuvant chemotherapy for colon cancer
Best Practice & Research Clinical Gastroenterology, 2002Colorectal cancer is one of the most frequent cancers in the world, especially in occidental countries. The primary curative therapy is surgical resection of the tumour. Within the last 15 years, appropriately powered prospective randomized trials have demonstrated that adjuvant post-operative chemotherapy should be the standard treatment for stage III
M, Ducreux, V, Boige
openaire +2 more sources